ArticleJournal of hematology & oncology2026

Five-year follow-up of patients with relapsed/refractory mantle cell lymphoma treated with anti-CD19 CAR T-cell therapy in ZUMA-2, Cohorts 1 and 2.

Javier Muñoz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.